Anne Nunes's most recent trade in Anika Therapeutics Inc. was a trade of 2,491 Common Stock done . Disclosure was reported to the exchange on Oct. 1, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 01 Oct 2024 | 2,491 | 14,211 (0%) | 0% | 0 | Common Stock | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 01 Oct 2024 | 2,491 | 0 | - | - | Restricted Stock Unit | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 01 Oct 2024 | 732 | 13,479 (0%) | 0% | 24.3 | 17,766 | Common Stock | |
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 15 Mar 2024 | 26,442 | 26,442 | - | - | Stock Option (Right to Buy) | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 15 Mar 2024 | 10,912 | 10,912 | - | - | Restricted Stock Unit | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 3,295 | 6,591 | - | - | Restricted Stock Unit | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 3,295 | 10,245 (0%) | 0% | 0 | Common Stock | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 2,561 | 2,561 | - | - | Restricted Stock Unit | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 2,561 | 11,838 (0%) | 0% | 0 | Common Stock | ||
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 968 | 9,277 (0%) | 0% | 25.4 | 24,607 | Common Stock | |
| Anika Therapeutics Inc. | Anne Nunes | SVP, Chief Operations Officer | 11 Mar 2024 | 752 | 11,086 (0%) | 0% | 25.8 | 19,394 | Common Stock |